Serum Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in Early/Late-onset Preeclampsia

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

December 30, 2018

Conditions
Preeclampsia
Interventions
OTHER

MMP-14 and s-ENG levels

Venous blood sampled from the antecubital veins for measuring the serum concentration of MMP-14 and s-ENG levels. The serum MMP-14 and s-ENG levels measured using commercially available reagent kits, which is produced to detect human MMP-14 and s-ENG levels (Rel Assay Diagnostics Gaziantep, Turkey). The MMP-14 and s-ENG levels measurements were performed in accordance with the company's protocol.

Trial Locations (1)

Unknown

Cengiz Gokcek Women's and Child's hospital, Gaziantep

All Listed Sponsors
lead

Cengiz Gokcek Women's and Children's Hospital

OTHER

NCT03932877 - Serum Soluble Endoglin and Matrix Metalloproteinase 14 With Elisa Method in Early/Late-onset Preeclampsia | Biotech Hunter | Biotech Hunter